Collaboration aimed at discovery of small molecule inhibitors targeting neurological disorders.
Category: Press Releases
Jubilant Biosys Announces Early Milestone in Collaborative Discovery Program
Jubilant Biosys announced today that they successfully achieved an early stage milestone related to a collaborative program with Sanofi in Frankfurt, Germany focused on metabolic disorders.
Jubilant Biosys Strengthens its Leadership Team with Two Key Appointments
Jubilant Biosys Ltd announced two new leadership appointments. Mr. Steven Hutchins has been appointed as President and Dr. Takeshi Yura has been appointed as Vice President of Medicinal Chemistry.
Jubilant Biosys and Sanofi Deutschland GmbH enter into a Strategic Alliance
Collaboration aimed at discovery and development of small molecule inhibitors through to Phase I proof of mechanism in metabolic disorders therapeutic area.